CellXplore Overview
- Year Founded
-
2007
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
CellXplore General Information
Description
Operator of a technology platform intended to facilitate the discovery of biomarkers. The company's technology platform is into identifying biomarkers for non-invasive diagnosis of breast cancer using biochemical analysis of blood samples, enabling clients to classify disease-specific biomarkers and target for drug discovery in human diseases and also apply it in the field of animal science.
Contact Information
Website
www.cellxplore.comCorporate Office
- 120 Albany Street, Tower II
- Suite 850
- New Brunswick, NJ 08901
- United States
Corporate Office
- 120 Albany Street, Tower II
- Suite 850
- New Brunswick, NJ 08901
- United States
CellXplore Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Sep-2018 | 00000 | Completed | Out of Business | ||
1. Early Stage VC | 01-Oct-2007 | 00000 | 00000 | Completed | Startup |
CellXplore FAQs
-
When was CellXplore founded?
CellXplore was founded in 2007.
-
Who is the founder of CellXplore?
Kiran Madura Ph.D is the founder of CellXplore.
-
Where is CellXplore headquartered?
CellXplore is headquartered in New Brunswick, NJ.
-
What industry is CellXplore in?
CellXplore’s primary industry is Biotechnology.
-
Is CellXplore a private or public company?
CellXplore is a Private company.
-
What is CellXplore’s current revenue?
The current revenue for CellXplore is 000000.
-
How much funding has CellXplore raised over time?
CellXplore has raised $500K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »